Biomerica (BMRA) EBIT Margin (2010 - 2026)

Biomerica (BMRA) reported EBIT Margin of 131.51% for Q1 2026, down 2338.0% on a YoY basis from 5.88% in Q1 2025, and down 15.9% sequentially from 113.47% in Q4 2025.

Biomerica (BMRA) EBIT Margin (2010 - 2026) Analysis & Trends

Biomerica (BMRA) has 17 years of EBIT Margin data on file, last reported at 131.51% in Q1 2026.

  • For the quarter ending Q1 2026, EBIT Margin fell 2338.0% year-over-year to 131.51%; the trailing twelve-month figure through Feb 2026 stood at 123.74% (down 3394.0% YoY), and the FY2025 full-year result was 96.72%, up 2086.0% from the prior year.
  • EBIT Margin slipped to 131.51% in Q1 2026, from 113.47% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 1.4% in Q1 2022 to a low of 208.81% in Q2 2025.
  • A 5-year average of 110.3% and a median of 112.42% in 2022 frame the typical range for EBIT Margin.
  • Across the five-year window, EBIT Margin surged 13027 bps in 2022 and tumbled 14720 bps in 2023, its largest moves.
  • Tracing BMRA's EBIT Margin over 5 years: stood at 112.42% in 2022, then increased by 9 bps to 102.62% in 2023, then jumped by 41 bps to 60.7% in 2024, then sank by 87 bps to 113.47% in 2025, then retreated by 16 bps to 131.51% in 2026.
  • Business Quant data shows BMRA's EBIT Margin at 131.51% in Q1 2026, 113.47% in Q4 2025, and 81.01% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Abbott Laboratories 183.83 Bn 176.54 Bn 6.27 Bn 12.05%
2 Stryker 128.96 Bn 126.08 Bn 3.81 Bn 15.55%
3 Medtronic 108.62 Bn 99.40 Bn 6.41 Bn 19.10%
4 Boston Scientific 68.62 Bn 67.16 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 48.35 Bn 44.67 Bn 1.29 Bn 28.97%
6 Dexcom 28.45 Bn 27.33 Bn 750.30 Mn 21.42%
7 GE HealthCare Technologies 28.18 Bn 25.90 Bn 1.98 Bn 10.04%
8 Smith & Nephew 26.91 Bn 26.33 Bn - -
9 Koninklijke Philips 24.68 Bn 21.55 Bn 2.07 Bn 6.17%
10 Biomerica 4.97 Mn 3.63 Mn -44,000.00 -131.51%

Historic Data

Download Data
DateValue
Feb 28, 2026 -131.51%
Nov 30, 2025 -113.47%
Aug 31, 2025 -81.01%
May 31, 2025 -208.81%
Feb 28, 2025 -108.13%
Nov 30, 2024 -60.70%
Aug 31, 2024 -75.71%
May 31, 2024 -136.92%
Feb 29, 2024 -196.66%
Nov 30, 2023 -102.62%
Aug 31, 2023 -71.92%
May 31, 2023 -165.70%
Feb 28, 2023 -148.60%
Nov 30, 2022 -112.42%
Aug 31, 2022 -126.45%
May 31, 2022 -33.13%
Feb 28, 2022 -1.40%
Nov 30, 2021 -24.31%
Aug 31, 2021 -122.06%
May 31, 2021 -163.40%